|
Sudeep Pharma Ltd
|
Registered Office:
129/1/A GIDC Estate Nandesari,
,
Vadodara
-
391340
,
Gujarat
, India.
Phone :
+91 265 284 0656/329 1354 Fax:
Email : cs.sudeep@sudeepgroup.com
Website : https://www.sudeeppharma.com
|
|
Initial public offer of 15,092,749 equity shares of face value of Re.1/- each ("equity shares") of Sudeep Pharma Limited ("company") for cash at a price of Rs593/- per equity share (including a share premium of Rs592/- per equity share) ("offer price") aggregating to Rs895.00 crores comprising a fresh issue of 1,602,023 equity shares of face value of Re.1/- aggregating to Rs95.00 crores by the company ("fresh issue") and an offer for sale of 13,490,726 equity shares of face value of Re.1/- aggregating to Rs800.00 crores ("offered shares") by the selling shareholders, consisting of 3,567,670 equity shares of face value of Re.1/- aggregating to Rs211.56 crores by SujitJjaysukh Bhayani, 8,418,856 equity shares of face value of Re.1/- aggregating to Rs499.24 crores by Sujeet Jaysukh Bhayani HUF, 750,000 equity shares of face value of Re.1/- aggregating to Rs44.48 crores by Shanil Sujit Bhayani and 754,200 equity shares of face value of Re.1/- aggregating to Rs44.72 crores by Avani Sujit Bhayani (collectively "the selling shareholders") and such equity shares offered by the selling shareholders ("offer for sale", and together with the fresh issue, the "offer").
Price Band: Rs593/- for equity share of face value of Rs1 each.
The floor price is 593 times times the face value times of the face value of the equity shares.
Bids can made for a minimum of 25 equity shares and in multiples of 25 equity shares thereafter.
|
|
|
|
Opens On
|
Closes On
|
Application
|
Allotment
|
|
|
21-Nov-25
|
25-Nov-25
|
Rs 593.00-0.00
|
Rs 0.00-0.00
|
|
Minimum Application for shares in Nos :25 Further
Multiples of :25
|
|
|
|
(Rs Cr)
|
Lead Managers to the Issue
|
|
|
Project Cost
|
88.48
|
|
|
Project Financed through Current Offer
|
895.00
|
|
|
Post Issue Equity Share Capital
|
11.29
|
|
|
Issue Price
|
Rs 593.00
|
|
|
|